Bicara Therapeutics Inc. (BCAX) vs Immatics N.V. (IMTX)
Bicara Therapeutics Inc. and Immatics N.V. are both Biotechnology companies. Bicara Therapeutics Inc. and Immatics N.V. are of similar size ($1.3B and $1.3B). Bicara Therapeutics Inc. has the higher net margin (0.00% vs −489.4%) and the higher return on invested capital (0.00% vs −84.8%). Across the 12 metrics below, Bicara Therapeutics Inc. leads on 10 and Immatics N.V. on 2.
Valuation
Profitability
| Metric | BCAX | IMTX | Biotechnology median |
|---|---|---|---|
| Gross margin | — | 100.00% | 65.16% |
| Operating margin | 0.00% | (536.26%) | 0.00% |
| Net margin | 0.00% | (489.35%) | 0.00% |
| Free cash flow margin | 0.00% | (488.01%) | 0.00% |
| Return on equity | (41.01%) | (48.53%) | (57.72%) |
| Return on assets | (38.38%) | (39.83%) | (49.22%) |
| Return on invested capital | 0.00% | (84.83%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack